Home/Filings/4/0001415889-24-012848
4//SEC Filing

Meckler Jeffrey A 4

Accession 0001415889-24-012848

CIK 0001438533other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 4:05 PM ET

Size

7.3 KB

Accession

0001415889-24-012848

Insider Transaction Report

Form 4
Period: 2024-05-08
Transactions
  • Award

    Common Stock

    2024-05-08+6,50081,000 total
  • Award

    Stock option (right to buy)

    2024-05-08+19,50019,500 total
    Exercise: $6.82From: 2025-05-08Exp: 2034-05-07Common Stock (19,500 underlying)
Footnotes (2)
  • [F1]Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
  • [F2]The equity award vests over a one year period.

Issuer

Travere Therapeutics, Inc.

CIK 0001438533

Entity typeother

Related Parties

1
  • filerCIK 0001506916

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:05 PM ET
Size
7.3 KB